Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
Search
Anthropic Confidentially Files for U.S. IPO
The Claude developer moved ahead of OpenAI as frontier AI companies prepare for public scrutiny.
Google DeepMind Licenses Contextual AI Technology and Hires Researchers
The $80 million to $90 million arrangement moves more than 20 employees without a formal company purchase.
Cerebras Shares Soar in $5.55 Billion Nasdaq Debut
The AI chipmaker nearly doubled its offering price as investors sought another route into compute infrastructure.
Anthropic Acquires Computer-Use Startup Vercept
The Seattle company's team and desktop-agent technology will support Claude's ability to operate software.
